Investigating the combinatory effect of Sclerocarya birrea with doxorubicin against selected colorectal cancer cell lines

Investigating the combinatory effect of Sclerocarya birrea with doxorubicin against selected colorectal cancer cell lines

Introduction: Colorectal cancer incidences continue to increase annually, worldwide. Herbal plants with antiproliferative properties received research interest as agents that can be adjuvant therapies with chemotherapy drugs to enhance their efficacy and reverse drug resistance. Methods: Sclerocary...

Full description

Saved in:

Bibliographic Details
Main Authors:	Thembelihle Nxasana, Innocensia Mangoato, Patriciah Masiu, Abhay Mishra, Motlalepula Matsabisa
Format:	Article
Language:	English
Published:	AboutScience Srl 2024-12-01
Series:	Drug Target Insights
Subjects:	Colorectal cancer Doxorubicin drug resistance Sclerocarya birrea Synergy Verapamil
Online Access:	https://journals.aboutscience.eu/index.php/dti/article/view/3219
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Systematic Review and Meta-Analysis of <i>Sclerocarya birrea</i> on Metabolic Disorders: Evidence from Preclinical Studies
by: Desirée Victoria-Montesinos, et al.
Published: (2024-11-01)

Mating System among Provenances of Sclerocarya birrea (A. Rich.) Hochst.
by: Violet J. Msukwa, et al.
Published: (2019-01-01)

Synthesis and Characterisation of Activated Carbon Obtained from Marula (Sclerocarya birrea) Nutshell
by: Tafadzwa Mkungunugwa, et al.
Published: (2021-01-01)

Yield and Physicochemical Properties of Marula (Sclerocarya birrea) Seed Oils among Nine International Provenances Tested in Malawi
by: Mussa Kamanula, et al.
Published: (2022-01-01)

Exploring the utilisation and management of Sclerocarya birrea (A. Rich.) Hochst (Marula tree) in the Beitbridge district of southern Zimbabwe
by: Sithembelenkosini Mguni, et al.
Published: (2023-12-01)

The supramolecular processing of liposomal doxorubicin hinders its therapeutic efficacy in cells
by: Annalisa Carretta, et al.
Published: (2024-09-01)

Dynamics of pathological changes of myocardial structures of rats under administration of doxorubicin
by: А. G. Rodinskij, et al.
Published: (2015-04-01)

Histopathological Evaluation of Erythropoietin's Protective Effect Against Doxorubicin-Induced Hepatotoxicity
by: Zeena Jasim Saddam, et al.
Published: (2025-05-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

The effects of peptide IF7-conjugated dendrimer loaded with doxorubicin on colorectal cancer
by: Omid Reza Tamtaji, et al.
Published: (2025-03-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer
by: Atefeh Ghahremanloo, et al.
Published: (2025-03-01)

Use of Moringa oleifera (Moringa) Seed Pods and Sclerocarya birrea (Morula) Nut Shells for Removal of Heavy Metals from Wastewater and Borehole Water
by: Irene Wangari Maina, et al.
Published: (2016-01-01)

Effect of Verapamil on the formation of adhesions in aseptic peritonitis
by: Sergey V. Skalskiy, et al.
Published: (2017-10-01)

Synergistic effects of abietic acid combined with doxorubicin on apoptosis induction in a human colorectal cancer cell line
by: Hesham Haffez, et al.
Published: (2025-05-01)

Pathophysiology of Doxorubicin-Mediated Cardiotoxicity
by: Roberto Arrigoni, et al.
Published: (2025-04-01)

Role of Bee Propolis and Vitamin E in Attenuating Doxorubicin-induced Hepatic Toxicity in Rats
by: Hodhaifa Abdul Mohsin, et al.
Published: (2025-04-01)

Bilateral Wilms Tumour: Is Neoadjuvant Doxorubicin Necessary?
by: Tristan Boam, et al.
Published: (2025-04-01)

Impact of Doxorubicin on Cardiac Function in Dogs: Ejection Fraction Changes and Heart Failure Risk
by: Gustavo Cavinato Herrera, et al.
Published: (2025-09-01)

Histopathological evaluation of the effects of thymoquinone and resveratrol on the liver in rats administered doxorubicin
by: Mehmet Burak Ates, et al.
Published: (2022-09-01)

The role of circRNAs in resistance to doxorubicin
by: Mahla Sanati, et al.
Published: (2024-11-01)

Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
by: V. Escudero-Ortiz, et al.
Published: (2014-05-01)

The correlation between the level of doxorubicin-induced cardiac damage and serum soluble Fas in an experimental rat model
by: Dogan Kose, et al.
Published: (2018-01-01)

Longitudinal Assessment of QT Apex in Tumor‐Bearing Dogs Receiving Doxorubicin Monotherapy
by: Keita Kitagawa, et al.
Published: (2025-07-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel—An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin
by: Lyubomira Radeva, et al.
Published: (2024-10-01)

Metabolomic profiling and biomarker identification for early detection and therapeutic targeting of doxorubicin-induced cardiotoxicity
by: Jingjing Ding, et al.
Published: (2025-04-01)

Potentiating Effect of Nitric Oxide Donor on Antitumor Activity of Doxorubicin in Glioblastoma-Bearing Rats
by: A. I. Alekseeva, et al.
Published: (2020-05-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

A Review: Neurotoxicity of Doxorubicin
by: Hanan Saadon, et al.
Published: (2025-06-01)

Assessment of circulating biomarkers in a rat model of doxorubicin-induced cardiotoxicity
by: Emilia ANCA, et al.
Published: (2024-12-01)

Ameliorative effects of agomelatine against doxorubicin-induced hepatotoxicity
by: Hasan Basri Savas, et al.
Published: (2025-08-01)

Apelinergic System Affects Electrocardiographic Abnormalities Induced by Doxorubicin
by: Kasper Buczma, et al.
Published: (2025-01-01)

Doxorubicin induced reversible cardiomyopathy: A Case report
by: K Tamakuwala, et al.
Published: (2015-07-01)

Can Dexrazoxane and Carvedilol prevent Doxorubicin-induced nephrotoxicity?
by: Szponar Jaroslaw, et al.
Published: (2024-12-01)

Kinetic and equilibrium studies of doxorubicin adsorption on MCM-41-type silica surface
by: N. V. Roik, et al.
Published: (2016-11-01)

Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells
by: Enrico Gallo, et al.
Published: (2025-02-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2015-04-01)

Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review
by: Shang W, et al.
Published: (2025-07-01)

Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
by: Windy Aristiani, et al.
Published: (2024-04-01)